It is reported that NDRG2 could antagonize transforming growth factorβ1-mediated tumor cell invasion by specifically down-regulating the expression of matrix metalloproteinase 2 and laminin 332 pathway components, with concomitant suppression of Rho GTPase activity in hepatocellular carcinomas [22]. This evidence concerns the gene MMP2 and hepatocellular carcinoma.